Hypoparathyroidism Treatment Market Will Reach at a CAGR of 8% From 2018 to 2026
Search jobs Hypoparathyroidism Treatment Market Will Reach at a CAGR of 8% From 2018 to 2026 The global hypoparathyroidism treatment landscape that only gained much significance post the FDA approval of Natpara in 2015, is projected grow at a rather robust CAGR of approximately 8% through 2026. As per a recent in-depth analysis by Future Market Insights (FMI), the valuation of global hypoparathyroidism treatment market is expected to stand at US$ 663.7 Million in 2019. Although the growth rate is expected to showcase similar trends, the global hypoparathyroidism tre...
Source: pharmiweb.com